Success Stories: Our Team of Experts Helped a Postdoctoral Fellow in Oncology from Ghana Get NIW Approval, Without RFE


Client’s Testimonial:

“Thank you all for your help in securing the I-140.”

On August 18th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Oncology (Approval Notice).

General Field: Oncology

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: Ghana

State of Residence at the Time of Filing: Maryland

Approval Notice Date: August 18th, 2021

Processing Time: 10 months, 19 days

Case Summary:

“[Client’s] work on breast cancer therapy stands out in particular because of the high prevalence of the disease among women in the United States. About 1 in 8 women in the United States will develop invasive breast cancer over the course of her lifetime. Considering the high national death toll of breast cancer and the moral imperative we have as a nation to discover more effective treatments, it is clear that [client’s] work possesses enormous value to the United States.”

“The National Cancer Institute estimates about 14,000 cases of glioblastoma are diagnosed each year in the United States. In order to develop a cure for this devastating illness, additional research into new therapeutic targets for drug development is necessary. To this end, I am writing today to recommend the work of [the client], an oncology researcher whose work to identify novel therapeutic targets for the treatment of glioblastoma has greatly advanced our knowledge of this disease and enabled necessary research to develop more effective care.”

These are two passages taken from letters of support furnished by our client, a postdoctoral fellow in the field of oncology from Ghana. As an expert in the field of oncology, her proposed endeavor is to continue her research on investigating the genetic mechanisms behind tumor growth and development in order to design novel therapeutics for solid and hematological malignancies. When she approached us in September of 2020, she wanted us to help her file an NIW (National Interest Waiver) petition on her behalf. So we engaged our team to find out more about her work and we quickly discovered that her research advancing her proposed endeavor is of great importance because her findings improve the efficacy of novel cancer treatment techniques and compounds such as proteolysis targeting chimera (PROTAC) compounds. The development of innovative protocols and treatment methodologies is essential for supporting global public health, as cancer is a severe health detriment.

We were able to confirm that the dire international need for advanced cancer therapeutics and treatment methodologies is being fulfilled in part by her novel research, in addition to which her proposed endeavor has broad implications for the United States. Specifically, her findings are relevant for the treatment of breast cancer and glioblastomas in the United States. Breast cancer is particularly common in the United States, as this is calculated to affect about 12% of U.S. women during their lifetime.

In recognition of the value and importance of her work, it has been granted funding by the National Cancer Institute. This institution is dedicated to developing innovative cancer treatment protocols, and its funding is incredibly competitive. On the other hand, her research has resulted in 10 peer-reviewed journal articles (two of them first-authored). Moreover, these papers have been published in the top journals in her field, reflecting her peers’ recognition of the value of this research. Six of these papers rank among the top 10% of most-cited articles across the entire field of clinical medicine for their respective years of publication. Not only has she successfully completed and published the results of her research in the field, but her research has also gone on to influence her peers. That is, her publications have been cited a total of 196 times according to Google Scholar.

All of this information put together made for a very compelling case that the USCIS had to approve. We are delighted and thankful to her for choosing us to represent her in this case. We look forward to seeing her progress in her field of expertise.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.

If you are interested in filing the green card, please send your CV to for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.

Approval Notices:

Success Stories:


Free evaluation email:

Tel: 888.666.0969 (Toll Free)

To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE

Copyright © North America Immigration Law, All Rights Reserved.